Civorebrutinib-d4

(Synonyms: WS-413-d4)

Civorebrutinib-d4 (WS-413-d4) is the deuterated-labeled Civorebrutinib (HY-111781). Civorebrutinib (WS-413) is a selective, orally active BTK and TEC inhibitor with an IC50 of <100 nM for both targets. Civorebrutinib inhibits B cell activation. Civorebrutinib significantly suppresses the in vivo growth of diffuse large B-cell lymphoma cells. Civorebrutinib can be used for the research of diffuse large B-cell lymphoma.

For research use only. We do not sell to patients.

  • Formula: C23H18D4ClN7O2
  • Molecular Weight:467.94
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00